J&J in talks to reduce $1.5 bln Elan deal price: source

BOSTON/NEW YORK (Reuters) – U.S. health-care firm Johnson & Johnson is in talks to cut the price of a $1.5 billion deal with Irish drugmaker Elan Corp , a source familiar with the negotiations said on Sunday.

A restraint too far

Comments in chronological order (Total comment) Loading 0% complete Loading comments… In order to post a comment you need to be registered and signed in.

AIM MARKET: Slim return from push for foreign listings

Next month, two years will have passed since the London Stock Exchange unveiled plans to launch a Japanese growth market, bearing the Aim brand, in partnership with its Tokyo counterpart. It is longer still since Dame Clara Furse, the former chief

Itching to stop smoking? Scientists may know why

LONDON (Reuters) – Scientists think they have discovered why people trying to quit smoking often find they are itching to stop.

Nanotech safety: Smaller particles may be riskier

CHICAGO (Reuters) – In determining the safety of improbably small materials known as nanoparticles, special properties associated with some of the very smallest particles may be the key, scientists said on Sunday.